2882 SAND HILL ROAD, MENLO PARK, CA
Summit Therapeutics Inc. Annual Meeting - Director Elections and Auditor Rati...
Summit Therapeutics Withdraws Proposed Public Offering Due to Market Conditions
Other Events
Investor Presentation
Annual Report to Security Holders
FY 2024
Q3
Q2
Q1
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Registration Statement for Securities to be Offered to Employees
Notice of Exempt Offering of Securities
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence